About
Jeffrey Sprouse is a neuropharmacologist and biopharma drug-development executive focused on neuroscience, psychiatry, and other CNS-related therapeutic areas. Public sources place him in senior preclinical and pipeline-development roles at Pfizer, Lundbeck Research USA, Bioasis Technologies, Diamond Therapeutics, and as an employee/co-author affiliated with Anavex Life Sciences. His profile is that of a scientific/operator figure rather than a capital deployer.
Areas of interest
biotechdrug discoveryneuroscienceneuropharmacologypsychiatrymental healthCNS therapeuticspsychedelicsblood-brain barrier deliveryneurodevelopmental disorderspreclinical research